Cambridge, United Kingdom

Michele Writer

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Crescendo Biologics Limited. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michele Writer. Retrieved from https://idiyas.com/inventor/michele-writer-5z8ndyr3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2022-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michele Writer: Innovator in Therapeutic Molecules

Introduction

Michele Writer is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of therapeutic molecules, particularly in the treatment of cancer. With a total of 2 patents, Michele has focused his research on binding molecules that target prostate-specific membrane antigen (PSMA).

Latest Patents

Michele's latest patents involve innovative binding molecules that specifically attach to PSMA. These inventions include single human variable heavy chain domain antibodies and related methods for cancer treatment. His work aims to enhance the effectiveness of therapies for patients suffering from prostate cancer.

Career Highlights

Michele Writer is currently associated with Crescendo Biologics Limited, where he continues to advance his research in therapeutic molecules. His expertise in this area has positioned him as a key player in the development of novel cancer treatments.

Collaborations

Michele collaborates with talented individuals such as Brian Timothy McGuinness and Isabelle Osuch, who contribute to his innovative projects. Their combined efforts aim to push the boundaries of current medical treatments.

Conclusion

Michele Writer's work in therapeutic molecules represents a significant advancement in cancer treatment. His dedication to innovation and collaboration continues to inspire progress in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…